EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cell Biology of Human Cytomegalovirus Latency: Implications for Pathogenesis and Treatment

Matthew B Reeves iD

Reviews in Medical Virology · 2025

DOI: 10.1002/rmv.70063 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Medical Virology, 2025. Verfasst von Matthew B Reeves. Beteiligte Einrichtung: UCL Division of Infection & Immunity, Institute of Immunity & Transplantation, London, UK. Hauptthemen laut MEDLINE: Virus Latency, Cytomegalovirus, Cytomegalovirus Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, Kidney Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human cytomegalovirus (HCMV), like all herpes viruses, can establish lifelong infections of the host. This is due to the capacity to establish latency—a defining characteristic of herpes virus infection. In healthy individuals, pathology associated with HCMV infection is rare due, in part, to a robust immune response that controls replication. Consequently, in patients with impaired immune responses substantial pathogenesis is observed due to a failure of immunological control. In this review, I discuss the biology of latency and reactivation with an emphasis on aspects important for our understanding of pathogenesis and treatment. In particular, I will represent how fundamental understanding of the cellular and molecular details of viral latency have, and will continue to be, pivotal for attempts to therapeutically target latent HCMV with a view to reducing the burden of disease. This will include pharmacological and immunological therapies that utilise the modulation of both host and viral functions important for latency and reactivation as well as strategies to harness the very well characterised and prodigious immune response directed against replicating HCMV to target latent infections as well.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus LatencyCytomegalovirusCytomegalovirus InfectionsHumansVirus ActivationHost-Pathogen Interactions

Stichwörter der Autor:innen

US28epigeneticshaematopoiesisimmune controllatencytransplantation

Autor:innen und Institutionen

  • UCL Division of Infection & Immunity, Institute of Immunity & Transplantation, London, UK.

ORCID-Profile: Matthew B Reeves

Förderung

  • Medical Research Council
  • Wellcome Trust
  • Kidney Research
  • Rosetrees Trust

Zitieren

APA

Reeves, M. B. (2025). Cell Biology of Human Cytomegalovirus Latency: Implications for Pathogenesis and Treatment. Reviews in Medical Virology. https://doi.org/10.1002/rmv.70063

Vancouver

Reeves MB. Cell Biology of Human Cytomegalovirus Latency: Implications for Pathogenesis and Treatment. Reviews in Medical Virology. 2025. doi:10.1002/rmv.70063

BibTeX
@article{Reeves2025,
  author = {Reeves, Matthew B},
  title = {Cell Biology of Human Cytomegalovirus Latency: Implications for Pathogenesis and Treatment},
  journal = {Reviews in Medical Virology},
  year = {2025},
  doi = {10.1002/rmv.70063}
}
Kostenlos starten →